A team of experts supporting you and your patients.
Our team of Kineret experts include Case Managers, Pharmacy Specialists, and Kineret Trained Nurses. They are here to help support you, your team, and your patients by providing assistance with prescription delivery, insurance, and reimbursement, and answers to some of their Kineret-related questions.
Kineret Case Managers can guide you and your patients through the insurance approval process and help find access solutions
Insurance coverage verification
Prior Authorization support
Co-Pay Program with financial support for eligible patients
Kineret Pharmacy Specialists will deliver your patient’s prescription right to their door. The first time. And every time.
Prescription delivery directly to their home
Free sharps containers and needle clippers
Information about Kineret RxCrossroads is a pharmacy that fills and ships their prescription.
Kineret Trained Nurses can help your patients with injection training
One-on-one injection training and in-home visits
Tips to help address common injection site reactions
Advice on injection site rotation and tracking
Helpful insights on issues from medication storage to travel
Patients can sign up for KINERET On TRACK Guidance to receive extra support
Tips as their medical needs evolve
Communications from our team of experts
Educational materials that help them know what to expect
Online resources packed with useful information
Kineret is only available through the KINERET On TRACK program.
To get started, download our enrollment forms here and complete them with your doctor.
If you have questions, please call 866-547-0644 from 8:00 a.m to 8:00 p.m ET, Monday through Friday, to speak with a specialist.
Kineret® is an interleukin-1 receptor antagonist indicated for:
Rheumatoid Arthritis (RA)
Reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease-modifying antirheumatic drugs (DMARDs).
Cryopyrin-Associated Periodic Syndromes (CAPS)
Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
IMPORTANT SAFETY INFORMATION
Kineret is contraindicated in patients with known hypersensitivity to E. coli-derived proteins, Kineret, or to any components of the product
In RA, discontinue use if serious infection develops. In Kineret-treated NOMID patients, the risk of a NOMID flare when discontinuing Kineret treatment should be weighed against the potential risk of continued treatment. Do not initiate Kineret in patients with active infections
Use in combination with Tumor Necrosis Factor (TNF) blocking agents is not recommended
Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported
The impact of treatment with Kineret on active and/or chronic infections and the development of malignancies is not known
Live vaccines should not be given concurrently with Kineret
Neutrophil counts should be assessed prior to initiating Kineret treatment, and while receiving Kineret, monthly for 3 months, and thereafter quarterly for a period up to 1 year
RA: Most common adverse reactions (incidence ≥ 5%) are injection site reaction, worsening of rheumatoid arthritis, upper respiratory tract infection, headache, nausea, diarrhea, sinusitis, arthralgia, flu-like symptoms, and abdominal pain
NOMID: The most common AEs during the first 6 months of treatment (incidence > 10%) are injection site reaction, headache, vomiting, arthralgia, pyrexia, and nasopharyngitis
A higher rate of serious infections has been observed in RA patients treated with concurrent Kineret and etanercept therapy than in patients treated with etanercept alone. Use of Kineret in combination with TNF blocking agents is not recommended
Because there is a higher rate of infections in the elderly population in general, caution should be used in treating the elderly
Kineret is substantially excreted by the kidney, and the risk of toxic reactions to Kineret may be greater in patients with impaired renal function